Division Chief of Markey Hematology ...

Dr. Gerhard Hildebrandt, MD

Claim this profile

University of Kentucky/Markey Cancer Center

Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
6 reported clinical trials
16 drugs studied

Area of expertise

1

Acute Myelogenous Leukemia

Gerhard Hildebrandt, MD has run 4 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:

PML-RARA negative
FLT3 negative
t(8;21) negative
2

Acute Myeloid Leukemia

Gerhard Hildebrandt, MD has run 4 trials for Acute Myeloid Leukemia. Some of their research focus areas include:

PML-RARA negative
FLT3 negative
t(8;21) negative

Affiliated Hospitals

Image of trial facility.

University Of Kentucky/Markey Cancer Center

Image of trial facility.

University Of Kentucky

Clinical Trials Gerhard Hildebrandt, MD is currently running

More about Gerhard Hildebrandt, MD

Clinical Trial Related

6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Gerhard Hildebrandt, MD has experience with

  • Cytarabine
  • Daunorubicin
  • Uproleselan
  • Blinatumomab
  • Ipilimumab
  • Nivolumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Gerhard Hildebrandt, MD specialize in?

Is Gerhard Hildebrandt, MD currently recruiting for clinical trials?

Are there any treatments that Gerhard Hildebrandt, MD has studied deeply?

What is the best way to schedule an appointment with Gerhard Hildebrandt, MD?

What is the office address of Gerhard Hildebrandt, MD?

Is there any support for travel costs?